Expert review finds risk without benefits in potential hep B vaccine change

The researchers found a delay would not improve the vaccine's safety or effectiveness.

December 2, 2025 Check out STAT+

Sponsored By

FDA STAT+ | Top drug regulator Richard Pazdur set to leave the FDA Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month. By Lizzy Lawrence Expert review finds delaying the hepatitis B vaccine birth dose would increase chronic infections in kids New report warns pushing back hepatitis B birth shots could sharply raise preventable infections. CDC vaccine panel will consider policy change this week. By Helen Branswell STAT+ | CDC staff with disabilities feel stranded as HHS implements new policy New HHS reasonable accommodations policy permits telework, but CDC officials plan to cancel existing agreements. By O. Rose Broderick Courtesy Peter Menzel STAT+ | Marion Nestle still believes that 'calories count' Marion Nestle, author of 'What to Eat Now,' discusses calories, changes to federal dietary guidelines, and why people ask her what she eats in a STAT Q&A. By Sarah Todd STAT+ | CMS to end historic kidney disease payment experiment two years early CMS's End-Stage Renal Disease Treatment Choices model failed to show improvements in home dialysis or transplantation.  By Isabella Cueto STAT+ | Hospital groups sue the Trump administration to halt a 340B pilot program set to begin in January Drugmakers triggered the latest battle over the 340B program by seeking to replace upfront discounts with rebates. By Ed Silverman AIZAR RALDES/AFP via Getty Images Opinion: Racial bias in medicine can be as simple as dismissing Black patients as a 'hard stick' Racial bias in health care isn't always blatant. It doesn't always look like a refusal to treat or a catastrophic mistake. By Jahidah La Roche Opinion: States fail to require adequate cannabis product safety warnings None of the 24 states and District of Columbia with legalized marijuana products adequately warn users about health risks. By Howard Husock

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser